Venture Capital

OBIO awards $100K to a cancer therapy startup and launches a new training program, directly addressing the systemic funding barriers for women in life sciences.

Responding to soaring AI and manufacturing demand, Cumming Group unifies 600+ specialists to build the world's most advanced high-tech facilities.

With key hires from Thoratec and Medtronic, CorWave signals an aggressive push to commercialize its revolutionary undulating membrane heart pump technology.

Amid record gold prices, Solomon Global's key sponsorship of the Master Investor Show highlights a major shift as investors seek stability in tangible assets.

Serenity Medical's River stent is a landmark approval for severe IIH, a condition causing chronic pain and vision loss, primarily in young women.

Philadelphia entrepreneur David Adelman brings his Darco Spirits portfolio to PA, a strategic move blending local pride with national market ambition.

Extell Development appoints Innovo founder Andrew Chung as Co-CEO, a move poised to reshape its capital strategy and diversify beyond luxury condos.

With its lead drug for a rare pediatric liver disease entering late-stage trials, NorthSea Therapeutics adds a veteran drug developer to its board.

Vaso Corporation posts a record $89.1M revenue for 2025, fueled by its GE HealthCare partnership after divesting its healthcare IT unit.

A new, imageable liver cancer therapy is one step closer to patients, thanks to a strategic partnership securing a vital US-based medical isotope supply.

A key U.S. patent extends protection for a promising CRPS-1 drug, paving the way for a potential first-in-class treatment for the debilitating condition.

Longhorn Diagnostics unveils LHNVD-501, a novel antibody targeting a universal bacterial component, offering a new front against AMR and chronic inflammation.

As homes shrink, creativity expands. Rockler's new DIY challenge, led by a YouTube star, inspires makers to build big in small spaces for major prizes.

A new partnership provides early access to an investigational drug for FAP, offering a potential non-surgical therapeutic option for the first time.

Ducted Vortex unveils a patented turbine using ancient principles, promising to solve wind and solar's biggest problems. Is it a revolution or just hype?

With trillions locked in private startups, Earlyasset emerges from stealth to build the financial 'plumbing' for a more liquid secondary market.

EV charging firm Hypercharge signals a new era of aggressive expansion, hiring a corporate development expert as its co-founder steps down from the board.

As AI reshapes discovery, a new tool helps biotech and pharma firms see if they are visible in AI search results, tackling a critical new blind spot.

EAGLERIDER launches a limited, overnight Yamaha UTV tour, transforming Las Vegas into a gateway for high-octane desert exploration. Get ready to ride.

With a massive new funding round, Saronic is accelerating its plan to rebuild U.S. shipbuilding with AI-driven autonomous vessels at a WWII-era pace.